Exogenous pulmonary surfactant for acute respiratory distress syndrome in adults: A systematic review and meta-analysis

Experimental and Therapeutic Medicine

Volumn 5, Issue 1, 2013, Pages 237-242

  Zhang, Li Na ^a   Sun, Jun Ping ^a   xue, Xin Ying ^a   Wang, Jian Xin ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Acute respiratory distress syndrome; Meta analysis; Mortality; Pulmonary surfactant

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; DIPALMITOYLPHOSPHATIDYLCHOLINE; LUSUPULTIDE;

ACIDEMIA; ADULT RESPIRATORY DISTRESS SYNDROME; AEROSOL; AIRWAY OBSTRUCTION; APACHE; ARTIFICIAL VENTILATION; BODY RASH; BRADYCARDIA; BRONCHOSPASM; CLINICAL EFFECTIVENESS; CONSCIOUSNESS DISORDER; DRUG TOLERABILITY; HEART VENTRICLE EXTRASYSTOLE; HUMAN; HYPOTENSION; HYPOXEMIA; HYPOXIA; KIDNEY FAILURE; LUNG COMPLIANCE; META ANALYSIS; OXYGENATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SHOCK; SUPRAVENTRICULAR TACHYCARDIA; SYSTEMATIC REVIEW; TREATMENT DURATION;

EID: 84869479492     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.746     Document Type: Review

References (20)

1. Ware LB and Matthay MA: The acute respiratory distress syndrome. N Engl J Med 342: 1334-1349, 2000.
2. Villar J, Kacmarek RM, Perez-Mendez L and Aquierre-Jaime A: A high positive end-expiratory pressure, low tidal volume venti-latory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial. Crit Care Med 34: 1311-1318, 2000.
3. Adhikari N, Burns KE and Meade MO: Pharmacologic treatments for acute respiratory distress syndrome and acute lung injury: systematic review and meta-analysis. Treat Respir Med 3: 307-328, 2004.
4. Iwata K, Doi A, Ohji G, et al: Effect of neutrophil elastase inhibitor (sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis. Intern Med 49: 2423-2432, 2010.
5. Frerking I, Gunther A, Seeger W and Pison U: Pulmonary surfactant: functions, abnormalities and therapeutic options. Intensive Care Med 27: 1699-1717, 2001.
6. Haitsma JJ, Papadakos PJ and Lachmann B: Surfactant therapy for acute lung injury/acute respiratory distress syndrome. Curr Opin Crit Care 10: 18-22, 2004.
7. Duffett M, Choong K, Ng V, et al: Surfactant therapy for acute respiratory failure in children: a systematic review and meta-analysis. Crit Care 11: R66, 2007.
8. Davidson WJ, Dorscheid D, Spragg R, et al: Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis. Crit Care 10: R41, 2006
9. Kesecioglu J, Beale R, Stewart TE, et al: Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 180: 989-994, 2009.
10. Spragg RG, Taut FJ, Lewis JF, et al: Recombinant surfactant protein C-based surfactant for patients with severe direct lung injury. Am J Respir Crit Care Med 183: 1055-1061, 2011.
11. Bautin A, Khubulava G, Kozlov I, et al: Surfactant therapy for patients with ARDS after cardiac surgery. J Liposome Res 16: 265-272, 2006.
12. Peter J V, John P, Graham PL, et al: Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ 336: 1006-1009, 2008.
13. Fleiss JL: The statistical basis of meta-analysis. Stat Methods Med Res 2: 121-145, 1993.
14. Higgins JPT and Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558, 2002.
15. Weg JG, Balk RA, Tharratt RS, et al: Safety and potential effcacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome. JAMA 272: 1433-1438, 1994.
16. Anzueto A, Baughman RP, Guntupalli KK, et al: Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med 334: 1417-1421, 1996.
17. Gregory TJ, Steinberg K P, Spragg R, et al: Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 155: 1309-1315, 1997.
18. Spragg RG, Lewis J F, Wurst W, et al: Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant. Am J Respir Crit Care Med 167: 1562-1566, 2003.
19. Spragg RG, Lewis JF, Walmrath HD, et al: Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 351: 884-892, 2004.
20. Tsangaris I, Lekka ME, Kitsiouli E, et al: Bronchoalveolar lavage alterations during prolonged ventilation of patients without acute lung injury. Eur Respir J 21: 495-501, 2003.